{"success":true,"data":{"pressRelease":{"id":"124740","rtpr_id":"nPnNDT5va","ticker":"CAPR","exchange":"NASDAQ","all_tickers":["CAPR"],"title":"Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR","author":"PR Newswire","published_at":"2026-08-21T08:33:00.210Z","article_body":"Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR\n\nPR Newswire\n\nLOS ANGELES, Aug. 21, 2026\n\nLOS ANGELES, Aug. 21, 2026 /PRNewswire/ -- The DJS Law Group\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4757104-1&h=2241051295&u=https%3A%2F%2Fdjslawllp.com%2F&a=The+DJS+Law+Group)\n reminds investors of a class action lawsuit against Capricor Therapeutics,\nInc. (\"Capricor\" or \"the Company\") (NASDAQ: CAPR\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4757104-1&h=871026020&u=https%3A%2F%2Fwww.marketwatch.com%2Finvesting%2Fstock%2FCAPR&a=CAPR)\n) for violations of §§10(b) and 20(a) of the Securities Exchange Act of\n1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange\nCommission.\n\nShareholders who purchased shares of CAPR during the class period listed are\nencouraged to contact the firm regarding possible lead plaintiff appointments.\nAppointment as lead plaintiff is not required to partake in any recovery.\n\nCLASS PERIOD: December 17, 2025 to July 26, 2026\n\nDEADLINE: September 28, 2026\n\nCASE DETAILS: According to the Complaint, the Company made false and\nmisleading statements to the market. Capricor modified the statistical\nanalysis plan used in the analysis of clinical data for Deramiocel. The\nCompany failed to secure the FDA's agreement to this change before it\nresubmitted a Biologics License Application for the drug. Based on these\nfacts, Capricor's public statements were false and materially misleading\nthroughout the class period.\n\nIf you are a shareholder who suffered a loss, contact us to participate\n(mailto:David@djslawllp.com) .\n\nWHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor\nreturn through balanced counseling and aggressive advocacy. As one of the\nfounding partners of Schall Brown & Schwartz LLP (schallfirm.com), David\nSchwartz specializes in securities class actions, corporate governance\nlitigation, and domestic/international M&A appraisals. Our clients are\nsome of the largest and most sophisticated hedge funds and alternative asset\nmanagers in the world. The litigation claims of our clients are\nextraordinarily valuable assets that demand respect, focus, and results.\n\nJoin the case (mailto:David@djslawllp.com)  to recover your losses.\n\nThis press release may be considered Attorney Advertising in some\njurisdictions under the applicable law and rules of ethics.\n\nCONTACT:\n\nDavid J. Schwartz\n\nDJS Law Group\n\n274 White Plains Road, Suite 1\n\n Eastchester, NY 10709\n\nPhone: 914-206-9742\n\nEmail: David@djslawllp.com (mailto:David@djslawllp.com)\n\nView original\ncontent:https://www.prnewswire.com/news-releases/capricor-therapeutics-inc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--capr-302857089.html\n(https://www.prnewswire.com/news-releases/capricor-therapeutics-inc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--capr-302857089.html)\n\nSOURCE DJS Law Group LLP\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPnNDT5va","title":"Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR","author":"PR Newswire","ticker":"CAPR","created":"2026-08-21T08:33:00.210Z","tickers":["CAPR"],"exchange":"NASDAQ","article_body":"Capricor Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - CAPR\n\nPR Newswire\n\nLOS ANGELES, Aug. 21, 2026\n\nLOS ANGELES, Aug. 21, 2026 /PRNewswire/ -- The DJS Law Group\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4757104-1&h=2241051295&u=https%3A%2F%2Fdjslawllp.com%2F&a=The+DJS+Law+Group)\n reminds investors of a class action lawsuit against Capricor Therapeutics,\nInc. (\"Capricor\" or \"the Company\") (NASDAQ: CAPR\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4757104-1&h=871026020&u=https%3A%2F%2Fwww.marketwatch.com%2Finvesting%2Fstock%2FCAPR&a=CAPR)\n) for violations of §§10(b) and 20(a) of the Securities Exchange Act of\n1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange\nCommission.\n\nShareholders who purchased shares of CAPR during the class period listed are\nencouraged to contact the firm regarding possible lead plaintiff appointments.\nAppointment as lead plaintiff is not required to partake in any recovery.\n\nCLASS PERIOD: December 17, 2025 to July 26, 2026\n\nDEADLINE: September 28, 2026\n\nCASE DETAILS: According to the Complaint, the Company made false and\nmisleading statements to the market. Capricor modified the statistical\nanalysis plan used in the analysis of clinical data for Deramiocel. The\nCompany failed to secure the FDA's agreement to this change before it\nresubmitted a Biologics License Application for the drug. Based on these\nfacts, Capricor's public statements were false and materially misleading\nthroughout the class period.\n\nIf you are a shareholder who suffered a loss, contact us to participate\n(mailto:David@djslawllp.com) .\n\nWHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor\nreturn through balanced counseling and aggressive advocacy. As one of the\nfounding partners of Schall Brown & Schwartz LLP (schallfirm.com), David\nSchwartz specializes in securities class actions, corporate governance\nlitigation, and domestic/international M&A appraisals. Our clients are\nsome of the largest and most sophisticated hedge funds and alternative asset\nmanagers in the world. The litigation claims of our clients are\nextraordinarily valuable assets that demand respect, focus, and results.\n\nJoin the case (mailto:David@djslawllp.com)  to recover your losses.\n\nThis press release may be considered Attorney Advertising in some\njurisdictions under the applicable law and rules of ethics.\n\nCONTACT:\n\nDavid J. Schwartz\n\nDJS Law Group\n\n274 White Plains Road, Suite 1\n\n Eastchester, NY 10709\n\nPhone: 914-206-9742\n\nEmail: David@djslawllp.com (mailto:David@djslawllp.com)\n\nView original\ncontent:https://www.prnewswire.com/news-releases/capricor-therapeutics-inc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--capr-302857089.html\n(https://www.prnewswire.com/news-releases/capricor-therapeutics-inc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--capr-302857089.html)\n\nSOURCE DJS Law Group LLP\n\n\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-08-21T08:33:00.259621949Z","server_sent_at_ms":1787301180259},"received_at":"2026-08-21T08:33:00.309Z","source_url":"https://www.prnewswire.com/news-releases/capricor-therapeutics-inc-sued-for-securities-law-violations---contact-the-djs-law-group-to-discuss-your-rights--capr-302857089.html"},"analysis":{"id":"113706","press_release_id":"124740","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":["Allegations that Capricor failed to secure FDA agreement for statistical analysis plan changes before BLA resubmission"],"eventType":"legal_litigation","narrative":"DJS Law Group issued a solicitation to Capricor Therapeutics (CAPR) investors regarding a class action lawsuit alleging securities law violations between December 17, 2025, and July 26, 2026.\n\nThe complaint alleges that Capricor made false statements by modifying the statistical analysis plan for Deramiocel without securing FDA agreement prior to resubmitting its Biologics License Application.\n\nInvestors have until September 28, 2026, to seek lead plaintiff appointment, though participation is not required for potential recovery.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress."},"keyFigures":{},"quotedText":"","namedEntities":{"people":[{"name":"David J. Schwartz","role":"Partner, DJS Law Group"}],"products":["Deramiocel"],"companies":[{"name":"DJS Law Group","relationship":"plaintiff law firm"},{"name":"Capricor Therapeutics, Inc.","ticker":"CAPR","relationship":"defendant"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm solicitation issued by DJS Law Group. No new disclosure from the issuer; no certified class or settlement announced. This is a marketing notice regarding a lawsuit, not a material corporate event."},"tickerRelevance":{"others":[],"primary":"CAPR"},"globalImportance":15,"audienceRelevance":10,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"DJS Law Group issued a solicitation to Capricor Therapeutics (CAPR) investors regarding a class action lawsuit alleging securities law violations between December 17, 2025, and July 26, 2026.\n\nThe complaint alleges that Capricor made false statements by modifying the statistical analysis plan for Deramiocel without securing FDA agreement prior to resubmitting its Biologics License Application.\n\nInvestors have until September 28, 2026, to seek lead plaintiff appointment, though participation is not required for potential recovery.","key_figures":{},"named_entities":{"people":[{"name":"David J. Schwartz","role":"Partner, DJS Law Group"}],"products":["Deramiocel"],"companies":[{"name":"DJS Law Group","relationship":"plaintiff law firm"},{"name":"Capricor Therapeutics, Inc.","ticker":"CAPR","relationship":"defendant"}],"dollarAmounts":[]},"model_name":"glm-4.7","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-08-21T08:34:12.188Z","global_importance":15,"audience_relevance":10,"importance_components":{"tickerTier":"small-cap","eventGravity":"law-firm-solicitation","issuerAuthored":false}},"durationMs":71801,"modelName":"glm-4.7"}}